One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Search from 250 M+ research papersSearch from 250 M+ research papershttps://doi.org/10.1182/blood.v130.suppl_1.2875.2875
Copy DOI Journal: Blood |  Publication Date: Jun 25, 2021 |
 Citations: 1 |
Affiliation: Novartis (Switzerland), Moffitt Cancer Center, Cornell University, Cook County Health and Hospitals System, Huntsman Cancer Institute, Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa, Emory University, Vanderbilt University Medical Center, University of Alabama at Birmingham, Memorial Sloan Kettering Cancer CenterResults from Enestgoal: A Phase 2 Study of Treatment-Free Remission (TFR) in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Who Switched from Imatinib to Nilotinib
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
